-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathindex.qmd
31 lines (25 loc) · 1.94 KB
/
index.qmd
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
---
title: "Marian Klose"
toc: false
about:
template: trestles
image-width: 15em
links:
- icon: linkedin
text: LinkedIn
url: https://www.linkedin.com/in/marian-klose/
- icon: github
text: Github
url: https://github.com/marianklose
- icon: envelope
text: Email
url: mailto:[email protected]
image: img/profile_picture2.jpg
comments: false
---
## About me
<div style="text-align: justify;">
Hi there! I'm Marian Klose, currently a PhD student at [Freie Universitaet Berlin](https://www.bcp.fu-berlin.de/en/pharmazie/faecher/klinische_pharmazie/arbeitsgruppe_kloft/mitarbeiter/Doktoranden_innen/klose_marian/index.html){target="_blank"}, and part of the [PharMetrX](https://www.pharmetrx.de/){target="_blank"} graduate research training program.
How did I end up here? During my pharmacy studies I got into pharmacometrics pretty early on and loved the mix of computer science, pharmacy, and math. After my graduation, I headed to Florida for six months to work at the University of Florida's Center for Pharmacometrics and Systems Pharmacology, and also did a three-month internship at Boehringer Ingelheim to see if my interest would remain steady. And I was still fascinated by pharmacometrics, so I decided to start my PhD and applied to the PharMetrX program — and here I am today!
Thankfully, there are many helpful blogs and articles available that break down complex topics into simpler, more accessible concepts. Whenever I come across a concept I don’t fully understand (which happens quite often), I try to explain it to myself using a Quarto or RMarkdown document. Since I’m anyways creating these documents for myself, I thought I might as well share them as little blog posts. My goal really isn’t to produce perfectly polished content, but rather to document my own learning process and potentially help others who might be facing the same challenges.
</div>